查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1351069

2030 年藥用玻璃包裝市場預測：依部門市場和地區分類的全球分析

Pharmaceutical Glass Packaging Market Forecasts to 2030 - Global Analysis By Product (Vials, Bottles, Cartridges & Syringes and Ampoules), Drug Type (Generic, Branded and Biologic) and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥用玻璃包裝市場規模為 201 億美元，預計預測期內年複合成長率為 11.4%，到 2030 年將達到 429 億美元。

藥用玻璃包裝包括用於儲存和保護藥品的玻璃容器的生產和分銷。這些玻璃包裝透過提供無菌、不滲透的環境來保護藥物的完整性、效力和穩定性，從而在整個保存期限內保持藥物的有效性。藥用玻璃包裝有多種形狀，包括西林瓶、瓶子、安瓿和注射器，以適應各種藥物類型和輸送方法。

根據美國醫療保險和醫療補助服務中心的數據，美國全國醫療保健支出預計將以每年 5.4% 的速度成長，到 2028 年將達到 6.2 兆美元。

玻璃的商業價值隨著可回收性的增加而增加

玻璃具有高度可回收性，其永續性與人們日益關注的環境問題不謀而合。玻璃可以無限回收，且不會降低質量，使其成為具有環保意識的消費者和行業的首選。隨著永續性越來越受到關注，對用玻璃等可回收材料包裝的產品的需求不斷成長。這一趨勢不僅推動了市場成長，也強調了採用環保包裝解決方案的重要性，增加了玻璃包裝在各個領域的吸引力和競爭力。

有限的創新

儘管塑膠等行業憑藉新的製造技術和智慧包裝解決方案取得了迅速發展，但玻璃包裝的進展卻很緩慢。缺乏創新限制了玻璃有效滿足現代市場需求的潛力。與技術適應性更強的材料相比，傳統玻璃包裝的智慧包裝功能（例如追蹤、防篡改和消費者互動）不太可行。此外，製藥業需要專門的包裝，例如受控藥物控制釋放系統，這可能會因玻璃缺乏多功能性而受到阻礙。

新興國家製藥業的成長

新興國家不斷成長的醫療保健需求和不斷成長的中階人口正在推動對藥品和相應包裝解決方案的需求。玻璃包裝能夠確保藥品的完整性、穩定性和無菌性，並滿足嚴格的藥品品質要求。此外，對永續性和奢華包裝的關注也增加了玻璃的吸引力。透過利用新興國家快速成長的藥品市場，玻璃包裝製造商可以獲得龐大的基本客群，並為藥品的安全有效供應做出貢獻。

替代材料的重要性日益增加

隨著塑膠、紙張和其他材料的創新，工業界正在探索減輕重量、降低運輸成本和提高生物分解性的方案。隨著永續性越來越受到關注，人們認知到玻璃生產和運輸對環境的影響，玻璃的地位可能會下降。製造商面臨越來越大的壓力，需要選擇符合環保意識的消費者偏好的材料。在成本效率和環境友善等要素的推動下，向替代材料的轉變可能會課題玻璃在包裝領域的傳統主導地位，並影響其市場佔有率和成長軌跡。

COVID-19 的影響：

儘管多個行業經歷了供應鏈中斷和原料短缺，但 COVID-19 大流行對製藥業影響甚微。製藥公司對當地社區至關重要，因此不受關閉法規。一些包裝業務也不受關閉限制，並正在從事醫療保健生產和支援。市場上的營運商正在透過自動化流程和分配盡可能少的人力資源來應對與 COVID-19 相關的藥品包裝需求的增加，以防止病毒傳播。

預計瓶裝市場在預測期內將是最大的市場

作為各種液體藥品和固態劑型的主要容器，瓶子部分預計將出現良好的成長。其惰性和不可滲透的特性確保了藥品的穩定性和完整性，對於維持產品功效至關重要。瓶子有多種尺寸，從用於精確劑量的小滴管瓶到用於批量劑量的大容器。這些瓶子具有防篡改密封和兒童用瓶蓋等功能，以提高患者的安全。隨著製藥需求的發展和患者便利性變得越來越重要，瓶子在提供安全且易於使用的包裝解決方案以滿足製藥行業嚴格的法規要求方面發揮著至關重要的作用。

預計學名藥部門在預測期內年複合成長率最高

預計學名藥領域在預測期內將以最快的年複合成長率成長。學名藥是一種在生物學上與品牌藥物等效的非品牌藥物。學名藥通常採用玻璃包裝，提供了一種經濟高效的替代，同時保持了藥物的安全性和有效性。玻璃容器透過提供水分、氧氣和光線的屏障來確保學名藥的穩定性並保持效力。此類包裝解決方案有助於提高基本藥物的可負擔性和可近性。由於控制醫療成本的配合措施，對學名藥的需求持續增加，藥用玻璃包裝在為更​​多人帶來高品質、價值主導的醫療保健解決方案方面發揮著至關重要的作用。

佔比最高的地區

預計北美藥用玻璃包裝市場在預測期內將繼續佔據大部分市場佔有率。該地區對患者安全、藥品完整性和產品差異化的關注正在推動對高品質玻璃容器的需求。先進的製造能力和技術創新在北美產生了廣泛的藥用玻璃包裝解決方案，包括西林瓶、瓶子和注射器。大型製藥公司的存在和發達的醫療保健基礎設施正在推動優質包裝選擇的採用。此外，該地區對永續包裝的關注符合全球趨勢，北美在塑造藥用玻璃包裝格局方面發揮關鍵作用。

複合年複合成長率最高的地區：

由於製藥業的快速成長和醫療保健行業的擴張，預計亞太地區在預測期內將出現最高的年複合成長率。該地區對藥品的需求不斷成長，以及對產品安全和保存期限的日益重視，推動了對高品質玻璃包裝解決方案的需求。有利的法規情勢和不斷增加的可支配所得進一步推動了藥用玻璃包裝市場的發展。亞太地區的製造能力，加上主要企業的存在和創新技術，在供應各種玻璃容器、西林瓶和安瓿方面發揮著關鍵作用，這些玻璃容器、西林瓶和安瓿對於維持藥品的完整性和有效性至關重要。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球藥用玻璃包裝市場：依產品

  • 小瓶
    • 小瓶
    • 大瓶
  • 瓶子
    • 小瓶
    • 大瓶
  • 藥筒和注射器
  • 安瓿

第6章 全球藥用玻璃包裝市場：依藥品類型

  • 通用的
  • 品牌
  • 生物製劑

第7章 全球藥用玻璃包裝市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第8章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • Schott AG
  • Nipro Corporation
  • Owens-Illinois, Inc.
  • Arab Pharmaceutical Glass Co.
  • Sisecam Group
  • Stoelzle Oberglas GmbH
  • West Pharmaceutical Services, Inc.
  • Beatson Clark
  • Bormioli Pharma SpA
  • Corning Incorporated
  • Shandong Medicinal Glass Co., Ltd.
  • Ardagh Group SA
  • Piramal Enterprises Ltd.
  • Gerresheimer AG
Product Code: SMRC23756

According to Stratistics MRC, the Global Pharmaceutical Glass Packaging Market is accounted for $20.1 billion in 2023 and is expected to reach $42.9 billion by 2030 growing at a CAGR of 11.4% during the forecast period. The pharmaceutical glass packaging encompasses the production and distribution of glass containers designed to store and protects pharmaceutical products. These glass packaging solutions provide a sterile and impermeable environment that safeguards the integrity, potency, and stability of medications, ensuring they remain effective throughout their shelf life. Pharmaceutical glass packaging comes in various forms, such as vials, bottles, ampoules, and syringes, catering to diverse medication types and delivery methods.

According to the U.S. Centers for Medicare & Medicaid Services, the national health spending of the country is expected to grow at an annual rate of 5.4% and reach USD 6.2 trillion by 2028.

Market Dynamics:

Driver:

Commodity value of glass increased with recyclability

Glass is highly recyclable, and its sustainable nature aligns with increasing environmental concerns. The ability to be infinitely recycled without compromising quality makes glass a preferred choice for eco-conscious consumers and industries. As sustainability becomes a central focus, the demand for products packaged in recyclable materials, such as glass, has risen. This trend not only enhances the market's growth but also underscores the importance of adopting environmentally responsible packaging solutions, bolstering the attractiveness and competitiveness of glass packaging in various sectors.

Restraint:

Limited technological innovations

While industries like plastics have rapidly evolved with new manufacturing techniques and smart packaging solutions, glass packaging has experienced slower progress. This deficiency in innovation restricts the potential for glass to meet modern market demands effectively. Smart packaging features such as tracking, tamper-evidence, and interaction with consumers are less feasible in traditional glass packaging compared to more technologically adaptable materials. Moreover, the pharmaceutical industry's need for specialized packaging, such as controlled drug release systems, can be impeded by glass's relative lack of versatility.

Opportunity:

Growth of pharmaceutical industry in emerging economies

As these regions experience increasing healthcare needs and expanding middle-class populations, there is a higher demand for medicines and corresponding packaging solutions. Glass packaging's ability to ensure drug integrity, stability, and sterility aligns with the stringent quality requirements of pharmaceutical products. Moreover, the focus on sustainability and premium packaging enhances the appeal of glass. Capitalizing on the burgeoning pharmaceutical markets in emerging economies allows glass packaging manufacturers to tap into a significant customer base and contribute to the safe and effective delivery of medications.

Threat:

Increased relevance of alternate material

With innovations in plastics, paper, and other materials, industries are exploring options that offer lighter weight, reduced transportation costs, and improved biodegradability. As sustainability gains prominence, the perceived environmental impact of glass production and transportation might weaken its position. Manufacturers are increasingly pressured to choose materials that align with eco-conscious consumer preferences. This shift towards alternative materials, driven by factors such as cost efficiency and environmental considerations, challenges the traditional dominance of glass in packaging, potentially impacting its market share and growth trajectory.

COVID-19 Impact:

The COVID-19 pandemic experienced supply chain disruptions and a lack of raw materials in several industries, but it had little impact on the pharmaceutical sector. Pharmaceutical businesses were exempt from shutdown restrictions because they are vital to the community. A few of packaging businesses were also exempted from the lockdown limitations and were functioning to produce and support healthcare items. Businesses in the market are responding to the growing demand for packaging for pharmaceutical items connected to COVID-19 by automating their processes and allocating the fewest possible human resources in order to prevent the spread of the virus.

The bottles segment is expected to be the largest during the forecast period

The bottles segment is expected to have a lucrative growth serving as primary containers for various liquid medications and solid dosage forms. Their inert and impermeable properties ensure drug stability and integrity, vital for preserving product efficacy. Bottles come in a range of sizes, from small dropper bottles for precise dosing to larger containers for bulk medications. They offer features such as tamper-evident seals and child-resistant closures, enhancing patient safety. With evolving pharmaceutical needs and a growing focus on patient convenience, bottles play a pivotal role in providing secure and user-friendly packaging solutions that meet stringent regulatory requirements in the pharmaceutical industry.

The generic segment is expected to have the highest CAGR during the forecast period

The generic segment is anticipated to witness the fastest CAGR growth during the forecast period. Generic is non-branded medications that are bioequivalent to their branded counterparts. Generic pharmaceuticals often come in glass packaging, offering cost-effective alternatives while maintaining drug safety and efficacy. Glass containers ensure the stability of generic medicines by providing a barrier against moisture, oxygen, and light, preserving their potency. These packaging solutions contribute to the affordability and accessibility of essential medications. As the demand for generic drugs continues to rise due to healthcare cost containment efforts, pharmaceutical glass packaging plays a pivotal role in delivering high-quality, value-driven healthcare solutions to a broader population.

Region with largest share:

During the forecast period, it is expected that the North America Pharmaceutical Glass Packaging market will continue to hold a majority of the market share. The region's emphasis on patient safety, drug integrity, and product differentiation fuels the demand for high-quality glass containers. With advanced manufacturing capabilities and innovation, North America produces a wide array of pharmaceutical glass packaging solutions, including vials, bottles, and syringes. The presence of major pharmaceutical companies and a well-established healthcare infrastructure drives the adoption of premium packaging options. Additionally, the region's focus on sustainable packaging aligns with global trends, solidifying North America's significant role in shaping the pharmaceutical glass packaging landscape.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period due to its burgeoning pharmaceutical industry and expanding healthcare sector. The region's increasing demand for medicines, along with a growing focus on product safety and preservation, drives the need for high-quality glass packaging solutions. Favorable regulatory landscapes and rising disposable incomes further boost the pharmaceutical glass packaging market. Local manufacturing capabilities, coupled with the presence of key players and innovative technologies, contribute to Asia Pacific's significant role in supplying a wide range of glass containers, vials, and ampoules, essential for maintaining the integrity and efficacy of pharmaceutical products.

Key players in the market:

Some of the key players in Pharmaceutical Glass Packaging market include: Schott AG, Nipro Corporation, Owens-Illinois, Inc., Arab Pharmaceutical Glass Co., Sisecam Group,Stoelzle Oberglas GmbH, West Pharmaceutical Services, Inc., Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Shandong Medicinal Glass Co., Ltd., Ardagh Group S.A, Piramal Enterprises Ltd. and Gerresheimer AG.

Key Developments:

In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG's expertise with Corning's glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.

In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop new innovation and ideas about pharmaceutical packaging by focusing on augment reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.

In March 2023, Schott AG launched the production of FIOLAX®amber pharma glass in India with the aim to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.

Products Covered:

  • Vials
  • Bottles
  • Cartridges & Syringes
  • Ampoules

Drug Types Covered:

  • Generic
  • Branded
  • Biologic

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Packaging Market, By Product

  • 5.1 Introduction
  • 5.2 Vials
    • 5.2.1 Small vials
    • 5.2.2 Large vials
  • 5.3 Bottles
    • 5.3.1 Small bottles
    • 5.3.2 Large bottles
  • 5.4 Cartridges & Syringes
  • 5.5 Ampoules

6 Global Pharmaceutical Glass Packaging Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Generic
  • 6.3 Branded
  • 6.4 Biologic

7 Global Pharmaceutical Glass Packaging Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Schott AG
  • 9.2 Nipro Corporation
  • 9.3 Owens-Illinois, Inc.
  • 9.4 Arab Pharmaceutical Glass Co.
  • 9.5 Sisecam Group
  • 9.6 Stoelzle Oberglas GmbH
  • 9.7 West Pharmaceutical Services, Inc.
  • 9.8 Beatson Clark
  • 9.9 Bormioli Pharma S.p.A.
  • 9.10 Corning Incorporated
  • 9.11 Shandong Medicinal Glass Co., Ltd.
  • 9.12 Ardagh Group S.A
  • 9.13 Piramal Enterprises Ltd.
  • 9.14 Gerresheimer AG

List of Tables

  • Table 1 Global Pharmaceutical Glass Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 15 North America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 17 North America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 18 North America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 19 North America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 20 North America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 21 North America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 22 North America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 23 North America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 24 North America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 25 North America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 26 North America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 27 North America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 28 North America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 29 Europe Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 31 Europe Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 32 Europe Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 33 Europe Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 34 Europe Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 35 Europe Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 36 Europe Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 37 Europe Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 38 Europe Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 39 Europe Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 40 Europe Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 41 Europe Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 42 Europe Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 43 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 45 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 46 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 47 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 48 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 49 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 50 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 51 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 52 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 53 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 55 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 56 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 57 South America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 59 South America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 60 South America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 61 South America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 62 South America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 63 South America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 64 South America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 65 South America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 66 South America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 67 South America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 68 South America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 69 South America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 70 South America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 71 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 73 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 74 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 75 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 76 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 77 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 78 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 79 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 80 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 81 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 82 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 83 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 84 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)